PMID- 21163133 OWN - NLM STAT- MEDLINE DCOM- 20110408 LR - 20131121 IS - 2542-5641 (Electronic) IS - 0366-6999 (Linking) VI - 123 IP - 22 DP - 2010 Nov TI - Treatment of retinal vein occlusion in rabbits with traditional Chinese medicine Fufang XueShuan Tong. PG - 3293-8 AB - BACKGROUND: Retinal vein occlusion (RVO) is one of the most common causes of visual loss. Many approaches have been tried to treat central retinal vein occlusion (CRVO), and branch retinal vein occlusion (BRVO) with various results. However, there is no defined protocol and limited evidence to support the interventions currently used. The aim of this study was to assess the efficacy of the traditional Chinese medicine Fufang XueShuan Tong (FXST) in treating experimentally created RVO. METHODS: RVO model was first induced in forty-four pigmented rabbits through photocoagulation following injection of rose Bengal. The rabbits were divided into four groups based on the dose of FXST administered (212 mg/kg, 424 mg/kg, 848 mg/kg and control group). The rabbits were observed for four weeks after the procedure, using color fundus photography, fundus fluorescein angiography and electroretinogram examination. Vascular endothelial growth factor (VEGF), interleukin-6 and nitric oxide (NO) levels in the vitreous and histopathologic evaluation were monitored. RESULTS: The obstructed vessels in the treatment groups reopened or anastomosed faster than those in the control group (P < 0.05). The amplitude of maximum b wave and the oscillatory potential were significantly higher in the treatment groups than in the control group (P < 0.01). At both two weeks and four weeks, VEGF and IL-6 levels in the vitreous were significantly decreased in the treatment groups (P < 0.01), while NO levels were significantly elevated (P < 0.01). At the same time, histopathologic evaluation showed different retinal neuroepithelium structures in the different groups. Immunoreactivity of VEGF was greater in the control group than in the treatment groups. CONCLUSION: FXST was helpful in reconstructing retinal vessels in the RVO model, protecting retinal structures and improving visual function, and could inhibit the neovascular factor. FAU - Zhou, Dan AU - Zhou D AD - Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. FAU - Wei, Wen-Bin AU - Wei WB FAU - Yang, Cheng-Xun AU - Yang CX FAU - Ding, Ning AU - Ding N FAU - Liu, Yan AU - Liu Y FAU - He, Man-Lin AU - He ML FAU - Hou, Zhi-Jia AU - Hou ZJ FAU - Zhou, Jin-Qiong AU - Zhou JQ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Chin Med J (Engl) JT - Chinese medical journal JID - 7513795 RN - 0 (Drugs, Chinese Herbal) RN - 0 (Interleukin-6) RN - 0 (Vascular Endothelial Growth Factor A) RN - 31C4KY9ESH (Nitric Oxide) SB - IM MH - Animals MH - Drugs, Chinese Herbal/*therapeutic use MH - Interleukin-6/metabolism MH - Nitric Oxide/metabolism MH - Rabbits MH - Retinal Vein Occlusion/*drug therapy/metabolism MH - Vascular Endothelial Growth Factor A/metabolism EDAT- 2010/12/18 06:00 MHDA- 2011/04/09 06:00 CRDT- 2010/12/18 06:00 PHST- 2010/12/18 06:00 [entrez] PHST- 2010/12/18 06:00 [pubmed] PHST- 2011/04/09 06:00 [medline] PST - ppublish SO - Chin Med J (Engl). 2010 Nov;123(22):3293-8.